These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 19229464)
21. Left atrial minimum volume is more strongly associated with N-terminal pro-B-type natriuretic peptide than the left atrial maximum volume in a community-based sample. Hedberg P; Selmeryd J; Leppert J; Henriksen E Int J Cardiovasc Imaging; 2016 Mar; 32(3):417-25. PubMed ID: 26498654 [TBL] [Abstract][Full Text] [Related]
22. Biomarkers and arrhythmia recurrence following radiofrequency ablation of atrial fibrillation. Carballo D; Noble S; Carballo S; Stirnemann J; Muller H; Burri H; Vuilleumier N; Talajic M; Tardif JC; Keller PF; Mach F; Shah D J Int Med Res; 2018 Dec; 46(12):5183-5194. PubMed ID: 30178684 [TBL] [Abstract][Full Text] [Related]
23. Independent effect of atrial fibrillation on natriuretic peptide release. Sramko M; Wichterle D; Melenovsky V; Franekova J; Clemens M; Fukunaga M; Kautzner J Clin Res Cardiol; 2019 Feb; 108(2):142-149. PubMed ID: 30051184 [TBL] [Abstract][Full Text] [Related]
24. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume. Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355 [TBL] [Abstract][Full Text] [Related]
26. Correlation between N-Terminal Pro-Brain Natriuretic Peptide and Doppler Echocardiographic Parameters of Left Ventricular Filling Pressure in Atrial Fibrillation. Kim WS; Park SH J Cardiovasc Ultrasound; 2011 Mar; 19(1):26-31. PubMed ID: 21519489 [TBL] [Abstract][Full Text] [Related]
27. Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved. Karaliūtė R; Leleika A; Apanavičiūtė I; Kazakevičius T; Mizarienė V; Zabiela V; Kavoliūnienė A; Ragaišytė N; Urbonienė D; Šakalytė G Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013520 [TBL] [Abstract][Full Text] [Related]
28. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major. Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869 [TBL] [Abstract][Full Text] [Related]
29. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea. Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868 [TBL] [Abstract][Full Text] [Related]
30. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study. Xiao J; Persson AP; Engström G; Johnson LSB BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943 [TBL] [Abstract][Full Text] [Related]
31. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure]. Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610 [TBL] [Abstract][Full Text] [Related]
32. The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation. Stanciu AE; Vatasescu RG; Stanciu MM; Serdarevic N; Dorobantu M Cytokine; 2018 Mar; 103():63-68. PubMed ID: 29324263 [TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention. Siva Sankara C; Rajasekhar D; Vanajakshamma V; Praveen Kumar BS; Vamsidhar A Indian Heart J; 2015; 67(4):318-27. PubMed ID: 26304563 [TBL] [Abstract][Full Text] [Related]
35. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging. Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440 [TBL] [Abstract][Full Text] [Related]
36. Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion. Tveit A; Seljeflot I; Grundvold I; Abdelnoor M; Arnesen H; Smith P Int J Cardiol; 2009 Jan; 131(2):234-9. PubMed ID: 18201783 [TBL] [Abstract][Full Text] [Related]
37. Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation. Miake J; Kato M; Ogura K; Iitsuka K; Okamura A; Tomomori T; Tsujimoto D; Kato M; Yamamoto K Heart Vessels; 2019 Mar; 34(3):517-526. PubMed ID: 30238353 [TBL] [Abstract][Full Text] [Related]
38. Use of preoperative natriuretic peptides and echocardiographic parameters in predicting new-onset atrial fibrillation after coronary artery bypass grafting: a prospective comparative study. Gibson PH; Croal BL; Cuthbertson BH; Rae D; McNeilly JD; Gibson G; Jeffrey RR; Buchan KG; El-Shafei H; Hillis GS Am Heart J; 2009 Aug; 158(2):244-51. PubMed ID: 19619701 [TBL] [Abstract][Full Text] [Related]
39. Association between the N-terminal plasma brain natriuretic peptide levels or elevated left ventricular filling pressure and thromboembolic risk in patients with non-valvular atrial fibrillation. Yu GI; Cho KI; Kim HS; Heo JH; Cha TJ J Cardiol; 2016 Aug; 68(2):110-6. PubMed ID: 26775889 [TBL] [Abstract][Full Text] [Related]
40. Predictors of left atrial fibrosis in patients with atrial fibrillation referred for catheter ablation. Rossi VA; Krizanovic-Grgic I; Steffel J; Hofer D; Wolber T; Brunckhorst CB; Ruschitzka F; Duru F; Breitenstein A; Saguner AM Cardiol J; 2022; 29(3):413-422. PubMed ID: 35285513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]